Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Ludwigsburg – page 3

35 clinical trials in Ludwigsburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Ludwigsburg at a glance
35
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

35 trials in Ludwigsburg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pemigatinib
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Amgen Inc.
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Eli Lilly & Co.

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Endometrial cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Ludwigsburg

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on breast cancer treatments, including innovative therapies for hormone receptor-positive and triple-negative variants. Multiple trials evaluating novel drug combinations and personalized treatment approaches.

  • Advanced breast cancer therapies
  • Colon cancer treatments
  • Ovarian cancer interventions

Investigations into chemotherapy optimization and targeted therapies for various cancer types.

02 Respiratory Medicine

Innovative research in non-small cell lung cancer treatment, exploring combinations of immunotherapy and chemotherapy. Studies focus on both early-stage and metastatic disease.

  • Advanced NSCLC treatments
  • Immunotherapy combinations
  • Targeted therapeutic approaches

Emphasis on personalized treatment strategies based on biomarker status.

03 Gastrointestinal Oncology

Comprehensive studies in gastric cancer and esophageal conditions, investigating new therapeutic combinations and organ preservation approaches.

  • Esophageal adenocarcinoma
  • Colorectal cancer therapy
  • Gastroesophageal junction tumors

Focus on multimodal treatment strategies combining surgery, chemotherapy, and immunotherapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.